Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 29, 2022VirusesOpen Access

Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab

View Full Paper
Ask AI
Bookmark
Share

Authors

SFShigeru FujitaTokyo Medical UniversityYKYusuke KosugiTokyo Medical UniversityIKIzumi KimuraNational Institute of Infectious Diseases

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fujita et al. (2022) studied this question.

synapsesocial.com/papers/6ab71dbfe6177a6874fb913ehttps://doi.org/10.3390/v14122677
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies2021 · 2,147 citations
  2. 2Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag2020 · 76 citations
  3. 3Modeling of loops in protein structures2000 · 2,195 citations